LSD1 activates oncogenic super-enhancers in castration-resistant prostate cancer by forming nuclear condensates with BRD4

被引：0
|
作者：
Liu, Mingyu
Li, Muqing
Han, Dong
Wang, Zifeng
Han, Wanting
He, Housheng Hansen
Gao, Shuai
Cai, Changmeng
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4729
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4729
引用
收藏
页数：2
相关论文
共 50 条
  • [1] LSD1 Inhibition Disrupts Super-Enhancer-Driven Oncogenic Transcriptional Programs in Castration-Resistant Prostate Cancer
    Li, Muqing
    Liu, Mingyu
    Han, Wanting
    Wang, Zifeng
    Han, Dong
    Patalano, Susan
    Macoska, Jill A.
    Balk, Steven P.
    He, Housheng Hansen
    Corey, Eva
    Gao, Shuai
    Cai, Changmeng
    CANCER RESEARCH, 2023, 83 (10) : 1684 - 1698
  • [2] Combinational therapy by targeting LSD1 and BRD4 in prostate cancer
    Li, Muqing
    Han, Dong
    Wang, Zifeng
    Gao, Shuai
    Cai, Changmeng
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [3] Targeting prostate cancer super enhancers by co-inhibiting LSD1 and BRD4.
    Gao, Shuai
    Li, Muqing
    Liu, Mingyu
    Han, Dong
    Wang, Zifeng
    Han, Wanting
    Cai, Changmeng
    CANCER RESEARCH, 2021, 81 (13)
  • [4] BRD4 Regulates Metastatic Potential of Castration-Resistant Prostate Cancer through AHNAK
    Shafran, Jordan S.
    Andrieu, Guillaume P.
    Gyorffy, Balazs
    Denis, Gerald V.
    MOLECULAR CANCER RESEARCH, 2019, 17 (08) : 1627 - 1638
  • [5] RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition
    Han, Wanting
    Liu, Mingyu
    Han, Dong
    Li, Muqing
    Toure, Anthia A.
    Wang, Zifeng
    Besschetnova, Anna
    Patalano, Susan
    Macoska, Jill A.
    Gao, Shuai
    He, Housheng Hansen
    Cai, Changmeng
    ONCOGENE, 2022, 41 (06) : 852 - 864
  • [6] The combined effect of epigenetic inhibitors for LSD1 and BRD4 alters prostate cancer growth and invasion
    Wang, Jianlin
    Yu, Qian
    Qiu, Zhaoping
    Dai, Tao
    Wang, Shuxia
    Yang, Xiuwei
    Evers, B. Mark
    Wu, Yadi
    AGING-US, 2020, 12 (01): : 397 - 415
  • [7] RB1 loss in castration-resistant prostate cancer confers vulnerability to LSD1 inhibition
    Wanting Han
    Mingyu Liu
    Dong Han
    Muqing Li
    Anthia A. Toure
    Zifeng Wang
    Anna Besschetnova
    Susan Patalano
    Jill A. Macoska
    Shuai Gao
    Housheng Hansen He
    Changmeng Cai
    Oncogene, 2022, 41 : 852 - 864
  • [8] BRD4 regulates key transcription factors that drive epithelial–mesenchymal transition in castration-resistant prostate cancer
    Jordan S. Shafran
    Naser Jafari
    Allison N. Casey
    Balázs Győrffy
    Gerald V. Denis
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 268 - 277
  • [9] LSD1 promotes castration-resistant prostate cancer cell survival independently of the androgen receptor and of histone demethylation
    Sehrawat, Archana
    Gao, Lina
    Tayou, Junior
    Bankhead, Armand
    Heiser, Laura M.
    King, Carly J.
    Wang, Yuliang
    Schwartzman, Jacob
    Urrutia, Joshua
    Coleman, Daniel J.
    Weinmann, Sheila
    Kallakury, Bhaskar V.
    Berry, Deborah L.
    Haque, Reina
    Van den Eeden, Stephen K.
    Beer, Tomasz M.
    Thomas, George V.
    McWeeney, Shannon
    Alumkal, Joshi J.
    CANCER RESEARCH, 2017, 77
  • [10] Histone demethylase LSD1 promotes castration-resistant prostate cancer by causing widespread gene expression derangements
    Li, Haiying
    Fan, Xiujie
    Fang, Xiuxiu
    Wang, Yunshan
    IUBMB LIFE, 2025, 77 (03)
12345